Patent · US Active

Compounds having CRTH2 antagonist activity

US7750027B2 · kind B2 · utility

17Cited by
28References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 24, 2009
Grant dateJul 6, 2010
Priority date—
Expiry dateNov 24, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of general formula (I)wherein

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.